Eckard Weber

Title: The Innovations of Eckard Weber

Introduction

Eckard Weber is a notable inventor based in Palo Alto, CA. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative peptide research. With a total of 3 patents, his work has implications for various medical applications.

Latest Patents

One of his latest patents involves gastrin releasing peptide-like peptides. These novel peptides, characterized by their unique structures, have been isolated from rat and guinea pig brain extracts and synthesized using solid phase peptide synthesis methods. The gastrin releasing peptide-like peptides are useful as pharmaceuticals to lower body temperature, increase respiratory activity, reduce food intake, stimulate pancreatic hormone release, stimulate pituitary hormone release, and suppress thyroid hormone release in mammals. Another significant patent focuses on the use of Arg-Phe-amide derivatives, which provides a method for elevating blood pressure in mammals through the administration of a polypeptide containing the C-terminal residue L-Arg-L-Phe or its esters or amides.

Career Highlights

Eckard Weber is affiliated with Leland Stanford Junior University, where he continues to advance his research and contribute to the scientific community. His work has garnered attention for its potential therapeutic applications.

Collaborations

Throughout his career, Eckard has collaborated with esteemed colleagues such as Jack D Barchas and Christopher J Evans. These partnerships have further enriched his research endeavors and expanded the impact of his innovations.

Conclusion

Eckard Weber's contributions to the field of pharmaceuticals through his innovative peptide research highlight the importance of scientific exploration in developing new medical therapies. His work continues to influence the landscape of pharmaceutical science.